Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.780
0.00 (0.00%)
Jan 28, 2026, 4:00 PM EST - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $168.84 million as of January 29, 2026. Its market cap has increased by 12.23% in one year.
Market Cap
168.84M
Enterprise Value
129.46M
1-Year Change
12.23%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $168.84M, an increase of 34.84%. That is a compound annual growth rate of 2.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 168.84M | -2.62% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 181.19M |
| Nkarta | 178.99M |
| Prelude Therapeutics | 177.98M |
| Eledon Pharmaceuticals | 174.58M |
| Corbus Pharmaceuticals Holdings | 170.09M |
| Protalix BioTherapeutics | 169.29M |
| Rani Therapeutics Holdings | 167.70M |
| Sol-Gel Technologies | 164.36M |